# A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

> **NCT04468815** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986278 Tablet
- **DRUG:** Esomeprazole
- **DRUG:** BMS-986278 suspension

## Key facts

- **NCT ID:** NCT04468815
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-10
- **Primary completion:** 2020-10-07
- **Final completion:** 2020-10-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468815, "A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04468815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*